One-liner#

Evaluation and management of urinary incontinence in older adults—classifying type (stress, urge, overflow, functional), identifying reversible causes, and implementing behavioral and pharmacologic treatments while avoiding anticholinergic medications that worsen cognition.

Quick nav#

• Red flags / send to ED
• Key history
• Focused exam
• Differential (quick pattern recognition)
• Workup
• Initial management
• Management by diagnosis
• Follow-up
• Patient instructions
• Smartphrase snippets

Red flags / send to ED#

• Acute urinary retention (unable to void, distended bladder, severe discomfort) → ED for catheterization
• New incontinence with acute neurologic symptoms (weakness, numbness, saddle anesthesia) → ED (cauda equina syndrome)
• Incontinence with fever, flank pain, and systemic illness → ED (pyelonephritis, urosepsis)
• Gross hematuria with clots → ED (may need irrigation)

Urgent (expedited outpatient):

• New-onset incontinence with back pain (spinal pathology)
• Incontinence with pelvic mass
• Recurrent UTIs with incontinence
• Incontinence causing significant skin breakdown

Key history#

Characterize the incontinence (determines type):

Quantify severity:

• Frequency of episodes (daily, weekly)
• Volume (drops, small amount, large amount, complete emptying)
• Pad use (number and type per day)
• Impact on quality of life, activities, sleep

Voiding diary (gold standard for assessment):

• 3-day record of fluid intake, voiding times, volumes, leakage episodes
• Identifies patterns and triggers
• Helps classify type

Associated symptoms:

• Dysuria, frequency, urgency (UTI)
• Hematuria (malignancy, stones, infection)
• Incomplete emptying (overflow)
• Weak stream, hesitancy, straining (obstruction)
• Nocturia (how many times per night)
• Constipation (can worsen incontinence)
• Prolapse symptoms (bulge, pressure)

DIAPPERS mnemonic (reversible causes):

• Delirium
• Infection (UTI)
• Atrophic vaginitis
• Pharmaceuticals (diuretics, anticholinergics, alpha-blockers, sedatives)
• Psychological (depression, severe anxiety)
• Excessive urine output (hyperglycemia, hypercalcemia, CHF, excessive fluid intake)
• Restricted mobility
• Stool impaction

Medication review:

• Diuretics (increase urine volume)
• Alpha-blockers (stress incontinence in women; improve flow in men)
• Anticholinergics (urinary retention → overflow)
• Cholinesterase inhibitors (increase bladder contractility → urge)
• Sedatives (impair awareness)
• Alcohol, caffeine (diuretics, bladder irritants)

Medical history:

• Diabetes (polyuria, neuropathy)
• Stroke, Parkinson’s, dementia (neurogenic bladder, functional incontinence)
• BPH (men—obstruction)
• Pelvic surgery, radiation
• Childbirth history (vaginal deliveries, large babies)
• Chronic cough (worsens stress incontinence)
• Obesity
• Constipation

Functional assessment:

• Mobility (can they get to bathroom quickly?)
• Dexterity (can they manage clothing?)
• Cognition (do they recognize urge, find bathroom?)
• Environment (bathroom accessibility, distance)

Focused exam#

Abdominal:

• Bladder distension (palpable bladder suggests retention)
• Masses
• Suprapubic tenderness

Pelvic exam (women):

• Atrophic vaginitis (pale, dry, friable mucosa)
• Pelvic organ prolapse:
  • Cystocele (anterior wall bulge)
  • Rectocele (posterior wall bulge)
  • Uterine prolapse
• Pelvic floor strength (ask patient to squeeze around examining fingers)
• Stress test: With full bladder, ask patient to cough—observe for leakage

Genital/rectal exam (men):

• Prostate size and consistency (BPH, cancer)
• Rectal tone (neurologic)
• Fecal impaction

Neurologic:

• Perineal sensation (S2-S4)
• Anal sphincter tone
• Lower extremity strength, reflexes
• Gait (if mobility is a factor)

Cognitive screen:

• If functional incontinence suspected

Post-void residual (PVR):

• Bladder scan or catheterization after voiding
• Normal: <50 mL
• Elevated: >200 mL suggests incomplete emptying (overflow)
• 50-200 mL: May be significant in symptomatic patients

Differential (quick pattern recognition)#

Common/likely (outpatient)#

Can’t-miss / urgent#

Workup#

Initial workup (all patients):

Additional testing based on clinical suspicion:

When NOT to order extensive workup:

• Classic stress or urge incontinence with normal UA and PVR
• Clear functional incontinence with known mobility/cognitive impairment
• Mild symptoms responding to behavioral treatment

Initial management#

Step 1: Address reversible causes (DIAPPERS)

• Treat UTI
• Treat atrophic vaginitis
• Adjust medications
• Treat constipation
• Optimize diabetes control
• Address mobility and environmental barriers

Step 2: Behavioral interventions (FIRST-LINE for all types)

Step 3: Pelvic floor physical therapy

• More effective than self-directed Kegels
• Biofeedback, electrical stimulation
• Refer for stress, urge, or mixed incontinence

Step 4: Pharmacologic treatment (if behavioral insufficient)

• See Management by Diagnosis below

Step 5: Specialist referral

• Failed conservative treatment
• Hematuria requiring evaluation
• Elevated PVR/retention
• Suspected neurologic cause
• Considering surgery

Management by diagnosis#

Urge incontinence / Overactive bladder (OAB)#

Education:

• The bladder muscle contracts when it shouldn’t, causing sudden urges
• Bladder training can retrain the bladder to hold more
• Medications can help but have side effects, especially in older adults

Behavioral treatment (first-line):

• Bladder training: Start voiding every 2 hours; increase by 15-30 min weekly; goal 3-4 hours
• Urge suppression: When urge hits, stop, squeeze pelvic floor, wait for urge to pass, then walk to bathroom
• Fluid management: 6-8 glasses/day; avoid caffeine, alcohol, artificial sweeteners
• Pelvic floor PT

Pharmacologic treatment:

Key point: Avoid anticholinergic bladder medications in elderly if possible. Use mirabegron or vibegron first. If anticholinergic needed, trospium may be safest for cognition.

Follow-up: 4-6 weeks to assess response; adjust or add therapy as needed.

Stress incontinence#

Education:

• The muscles that hold urine in are weak, so leakage happens with pressure
• Pelvic floor exercises (Kegels) strengthen these muscles
• It takes 6-12 weeks of consistent exercise to see improvement

Behavioral treatment (first-line):

• Pelvic floor muscle training (Kegels): Contract as if stopping urine; hold 10 seconds; relax 10 seconds; 3 sets of 10 daily
• Pelvic floor PT with biofeedback (more effective than self-directed)
• Weight loss if overweight
• Treat chronic cough
• Avoid heavy lifting

Devices:

• Pessary (vaginal support device)—fitted by urogynecology or trained provider
• Urethral inserts (for activity)

Pharmacologic treatment:

• No highly effective medications for stress incontinence
• Duloxetine (off-label): 40 mg BID; modest benefit; side effects limit use
• Topical vaginal estrogen: Helps if atrophic vaginitis contributing

Surgical options (urology/urogynecology referral):

• Midurethral sling (most common)
• Bulking agents
• Colposuspension

Follow-up: 6-12 weeks to assess response to pelvic floor training.

Mixed incontinence#

Education:

• You have features of both stress and urge incontinence
• We’ll treat the type that bothers you most first
• Often both improve with pelvic floor exercises

Treatment:

• Identify predominant type (which bothers patient more)
• Start with behavioral interventions (help both types)
• Add pharmacologic treatment for urge component if needed
• Consider surgery for stress component if severe and refractory

Follow-up: 4-6 weeks; reassess and adjust treatment.

Overflow incontinence#

Education:

• The bladder isn’t emptying completely, so it overflows
• We need to find out why—it could be a blockage or the bladder muscle not working
• Treatment depends on the cause

Evaluation:

• Confirm elevated PVR (>200 mL)
• Identify cause:
  • Obstruction (men): BPH, urethral stricture, prostate cancer
  • Obstruction (women): Severe prolapse, prior surgery
  • Underactive bladder: Diabetes, neurologic disease, medications

Treatment:

• If obstruction (BPH):
  • Alpha-blocker: Tamsulosin 0.4 mg daily
  • 5-alpha reductase inhibitor: Finasteride 5 mg daily (if prostate enlarged)
  • Urology referral for refractory cases or surgical options
• If underactive bladder:
  • Timed voiding (every 3-4 hours)
  • Double voiding (void, wait, void again)
  • Intermittent catheterization if PVR remains high
  • Avoid medications that worsen retention (anticholinergics, opioids)

Referral: Urology for obstruction evaluation, catheter management, or surgical options.

Follow-up: 2-4 weeks; recheck PVR after treatment.

Functional incontinence#

Education:

• The bladder works fine, but getting to the bathroom is the problem
• We can help by making it easier to get to the toilet and reminding you to go regularly

Treatment:

• Mobility barriers:
  • PT for gait and strength
  • Assistive devices (walker, cane)
  • Bedside commode or urinal
  • Clear path to bathroom; nightlights
• Cognitive barriers:
  • Timed voiding (every 2-3 hours)
  • Prompted voiding (caregiver asks regularly)
  • Easy-to-manage clothing (elastic waistbands, velcro)
  • Signs pointing to bathroom
• Environmental modifications:
  • Raised toilet seat
  • Grab bars
  • Adequate lighting

Containment products:

• Absorbent pads/briefs (not a treatment, but improves quality of life)
• Skin care to prevent breakdown

Follow-up: 2-4 weeks; assess effectiveness of interventions.

Atrophic vaginitis contributing to incontinence#

Education:

• After menopause, the vaginal and urethral tissues thin and dry out
• This can contribute to leakage and UTIs
• Vaginal estrogen can help restore the tissues

Treatment:

Note: Vaginal estrogen is safe in most women, including many breast cancer survivors (discuss with oncologist). Systemic absorption is minimal.

Follow-up: 4-8 weeks to assess response.

Follow-up#

Initial follow-up:

• 4-6 weeks after starting behavioral or pharmacologic treatment
• 2-4 weeks if addressing acute issue (UTI, retention)

What to reassess:

• Symptom improvement (frequency, volume, pad use)
• Voiding diary review
• Medication side effects (dry mouth, constipation, cognitive changes)
• PVR if on anticholinergic or if retention concern
• Quality of life impact

Ongoing management:

• Behavioral interventions are ongoing (not one-time)
• Reassess medications periodically (especially anticholinergics in elderly)
• Monitor for progression or new symptoms

When to refer:

• Failed conservative treatment (behavioral + medication)
• Hematuria requiring cystoscopy
• Elevated PVR not responding to treatment
• Considering surgical intervention
• Complex or unclear diagnosis

Patient instructions#

• Urinary incontinence is common but not a normal part of aging. There are treatments that can help.
• Bladder training and pelvic floor exercises are the first treatments we try. They take time to work—usually 6-12 weeks.
• To do pelvic floor exercises (Kegels): Squeeze the muscles you would use to stop urinating. Hold for 10 seconds, then relax for 10 seconds. Do 3 sets of 10 every day.
• Keep a bladder diary for 3 days: Write down when you drink, when you urinate, and when you leak. This helps us understand your pattern.
• Limit caffeine (coffee, tea, soda) and alcohol—they irritate the bladder.
• Don’t drink too little (you need fluids), but avoid drinking large amounts at once. Limit fluids in the evening to reduce nighttime trips.
• If you have a sudden urge, stop and squeeze your pelvic floor muscles. Wait for the urge to pass, then walk calmly to the bathroom.
• If you’re taking a new bladder medication, watch for dry mouth, constipation, or confusion. Let us know if these occur.
• Call us if you have blood in your urine, pain with urination, fever, or if you suddenly can’t urinate at all.

Smartphrase snippets#

.INCONTINENCEEVAL Urinary incontinence evaluation. Type: [stress / urge / mixed / overflow / functional]. Duration [X months/years]. Frequency: [X episodes per day/week]. Triggers: [cough/sneeze / urgency / constant dribbling / mobility]. Pad use: [X per day]. Impact on QOL: [minimal / moderate / significant]. UA: [normal / abnormal]. PVR: [X mL]. Pelvic exam: [normal / atrophy / prolapse / pelvic floor weakness]. Assessment: [Type] urinary incontinence. Plan: [Behavioral interventions / pelvic floor PT / medication / referral]. Follow-up in [4-6 weeks].

.INCONTINENCEBEHAVIORAL Behavioral treatment for urinary incontinence initiated. Counseled on: pelvic floor exercises (Kegels)—squeeze and hold 10 seconds, 3 sets of 10 daily; bladder training—void every [2-3] hours, gradually increase interval; fluid management—limit caffeine and alcohol, avoid fluids before bed; urge suppression techniques. Referred to pelvic floor PT for biofeedback. Will reassess in 6-8 weeks. Medications deferred pending response to behavioral treatment.

.OABTREATMENT Overactive bladder treatment. Behavioral interventions [ongoing / initiated]. Starting [mirabegron 25 mg daily / vibegron 75 mg daily] for urge incontinence. Chose beta-3 agonist over anticholinergic due to [age / cognitive concerns / anticholinergic burden]. Counseled on potential side effects (hypertension). Will monitor BP. Avoid anticholinergic bladder medications given [age / dementia / polypharmacy]. Follow-up in 4-6 weeks to assess response.

Coding/billing notes#

• N39.3: Stress incontinence (female)
• N39.41: Urge incontinence
• N39.46: Mixed incontinence
• N39.498: Other specified urinary incontinence (overflow)
• R32: Unspecified urinary incontinence
• N32.81: Overactive bladder
• N40.1: BPH with LUTS
• N95.2: Postmenopausal atrophic vaginitis
• R39.14: Feeling of incomplete bladder emptying
• R39.11: Hesitancy of micturition

Documentation tips:

• Document type of incontinence
• Document severity (frequency, pad use)
• Document PVR
• Document behavioral interventions counseled
• Document rationale for medication choice (especially avoiding anticholinergics)